Timothy P. Herbert - 18 Apr 2022 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
CEO and President, Director
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Timothy P. Herbert
Issuer symbol
INSP
Transactions as of
18 Apr 2022
Net transactions value
+$22,898
Form type
4
Filing time
22 Apr 2022, 19:56:33 UTC
Previous filing
13 Mar 2023
Next filing
13 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $13,555 +9,221 +177% $1.47* 14,445 18 Apr 2022 By family trust F1
transaction INSP Common Stock Options Exercise $9,343 +8,196 +57% $1.14* 22,641 18 Apr 2022 By family trust F1
holding INSP Common Stock 91,150 18 Apr 2022 Direct
holding INSP Common Stock 22,875 18 Apr 2022 By family trust F2
holding INSP Common Stock 113,138 18 Apr 2022 By GRAT F3
holding INSP Common Stock 350 18 Apr 2022 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -9,221 -100% $0.000000* 0 18 Apr 2022 Common Stock 9,221 $1.47 Direct F4, F5, F6
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -8,196 -100% $0.000000* 0 18 Apr 2022 Common Stock 8,196 $1.14 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
F2 Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.
F3 Securities held by the Timothy P. Herbert 2018 Grantor Retained Annuity Trust, under agreement dated December 12, 2018.
F4 The option is fully vested and exercisable.
F5 This option grant was previously reported as having an expiration date of April 30, 2022, which has been revised herein.
F6 Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly.